This content is in French.
Neutrophils: hidden accomplices in colorectal cancer?
23 mars 2026

By Ana Espino | Published on March 23, 2026 | 3 min readColorectal cancer (CRC) remains one of the leading causes of cancer-related mortality worldwide. While the role of T lymphocytes in tumor immunosurveillance is well established, the involvement of neutrophils—key cells of innate immunity—is drawing increasing attention. Long regarded as simple mediators of acute inflammation, neutrophils are
Colorectal cancer (CRC) remains one of the leading causes of cancer-related mortality worldwide. While the role of T lymphocytes in tumor immunosurveillance is well established, the involvement of neutrophils—key cells of innate immunity—is drawing increasing attention.
Long regarded as simple mediators of acute inflammation, neutrophils are now recognized as complex regulators of the tumor microenvironment. Their accumulation in colorectal tumors is associated with poorer clinical outcomes, although their functions remain heterogeneous and context-dependent.
Sign in to read the rest
Reserved for healthcare professionals, free registration.
Scientific reference
Wang X, et al. Neutrophils in colorectal cancer: mechanisms, prognostic value, and therapeutic implications. Front Immunol. 2025 Feb 28;16:1538635. doi: 10.3389/fimmu.2025.1538635. PMID: 40092983; PMCID: PMC11906667
View on PubMed


